ALC רווח למניה בשנים עשר החודשים האחרונים Alcon Vision

Alcon Inc. generates revenue through the sale of surgical instruments, cataract correction lenses, and eye care products. The TTM annual earnings per share metric helps filter out market noise, while the 1.30 value confirms the current yield level. The business is protected by stable demand for medical products without seasonal fluctuations, while growth is driven by the targeted acquisition of tech startups.

Portfolio managers value the operating model of Alcon Inc. (ALC), where trailing twelve-month earnings per share (EPS TTM) serves as the metric for real return on equity, stripped of the impact of share issuance. This rolling 12-month EPS chart confirms that structural demand for ophthalmology technologies is converting into sustainable profit growth, cementing the issuer's dominant position in the global market.